Anegon I - Search Results

1

Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat.

Aubert D, Ménoret S, Chiari E, Pichard V, Durand S, Tesson L, Moullier P, Anegon I, Ferry N. Aubert D, et al. Among authors: anegon i. Mol Ther. 2002 Apr;5(4):388-96. doi: 10.1006/mthe.2002.0561. Mol Ther. 2002. PMID: 11945065 Free article.

2

Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.

Charreau B, Cassard A, Tesson L, Le Mauff B, Navenot JM, Blanchard D, Lublin D, Soulillou JP, Anegon I. Charreau B, et al. Among authors: anegon i. Transplantation. 1994 Dec 15;58(11):1222-9. Transplantation. 1994. PMID: 7527603

3

Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.

Charreau B, Cassard A, Tesson L, Le Mauff B, Blanchard D, Lublin D, Soulillou JP, Anegon I. Charreau B, et al. Among authors: anegon i. Transplant Proc. 1995 Feb;27(1):336-7. Transplant Proc. 1995. PMID: 7533404 No abstract available.

4

Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.

Cuturi MC, Josien R, Cantarovich D, Bugeon L, Anegon I, Menoret S, Smit H, Douillard P, Soulillou JP. Cuturi MC, et al. Among authors: anegon i. Eur J Immunol. 1994 Jul;24(7):1627-31. doi: 10.1002/eji.1830240726. Eur J Immunol. 1994. PMID: 8026523

5

Leukaemia Inhibitory Factor derived from rat colon carcinoma cells increases host susceptibility to tumour growth.

Burg C, Patry Y, Le Pendu J, Moreau M, Tesson L, Godard A, Soulillou JP, Meflah K, Anegon I. Burg C, et al. Among authors: anegon i. Cytokine. 1995 Nov;7(8):784-92. doi: 10.1006/cyto.1995.0094. Cytokine. 1995. PMID: 8664445

6

Transgenesis in rats: technical aspects and models.

Charreau B, Tesson L, Soulillou JP, Pourcel C, Anegon I. Charreau B, et al. Among authors: anegon i. Transgenic Res. 1996 Jul;5(4):223-34. doi: 10.1007/BF01972876. Transgenic Res. 1996. PMID: 8755162 Review.

7

Analysis of human CD59 tissue expression directed by the CMV-IE-1 promoter in transgenic rats.

Charreau B, Tesson L, Buscail J, Soulillou JP, Anegon I. Charreau B, et al. Among authors: anegon i. Transgenic Res. 1996 Nov;5(6):443-50. doi: 10.1007/BF01980209. Transgenic Res. 1996. PMID: 8840527

8

In vitro and in vivo gene transfer in the rat: characterization of recombinant adenoviral vectors for rat interleukin-4 or interleukin-10 cDNA.

David A, Cassard A, Tesson L, Blancho G, Sigalla J, Charreau B, Godfrin Y, Smit H, Le Mauff B, Soulillou JP, Anegon I. David A, et al. Among authors: anegon i. Transplant Proc. 1997 May;29(3):1750-1. doi: 10.1016/s0041-1345(97)00042-0. Transplant Proc. 1997. PMID: 9142259 No abstract available.

9

Production of transgenic rats for human regulators of complement activation.

Charreau B, Tesson L, Menoret S, Buscail J, Soulillou JP, Anegon I. Charreau B, et al. Among authors: anegon i. Transplant Proc. 1997 May;29(3):1770. doi: 10.1016/s0041-1345(97)81999-9. Transplant Proc. 1997. PMID: 9142267 No abstract available.

10

Adenovirus-mediated gene transfer into isolated mouse adult pancreatic islets: normal beta-cell function despite induction of an anti-adenovirus immune response.

Sigalla J, David A, Anegon I, Fiche M, Huvelin JM, Boeffard F, Cassard A, Soulillou JP, Le Mauff B. Sigalla J, et al. Among authors: anegon i. Hum Gene Ther. 1997 Sep 1;8(13):1625-34. doi: 10.1089/hum.1997.8.13-1625. Hum Gene Ther. 1997. PMID: 9322095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters